A 61-year-old woman after total thyroidectomy for papillary thyroid cancer underwent I-131 therapy. Focal uptake was seen in the chest on whole body imaging. SPECT/CT delineated I-131 accumulation in an isodense mediastinal lesion which was histologically diagnosed as a thymic cyst. I-131 uptake in a thymic cyst is rare and should be included in the gamut of false-positive entities of I-131 scintigraphy.
FIGURE 1.
A 61-year-old woman who had undergone total thyroidectomy for papillary thyroid cancer received I-131 therapy under the withdrawal of thyroxine replacement. Thyroglobulin was negative with negative thyroglobulin antibody on the day of I-131 administration. On anterior whole-body imaging obtained on the third day after ingestion of 100mCi I-131, 2 intense foci in the neck (closed arrows), and focal uptake in the chest (open arrow) are seen (A). The former is likely to demonstrate the thyroglossal duct and a thyroid remnant. SPECT/CT reveals that the latter corresponds to an isodense mediastinal lesion which was surgically resected later (B, CT; C, SPECT; D, SPECT/CT, open arrows). Pathologic examination showed thymic cortex sparsely existed in the wall of a cystic component, resulting in the diagnosis of thymic cyst (E). The lesion contains neither thyroid tissue nor metastatic foci of thyroid cancer. Considering that rat thymus glands accumulate I-131, 1,2 thymic cortex in the cyst wall is speculated to have accumulated I-131 in this particular case.
I-131 scintigraphy is a useful method in the detection of thyroid remnants and metastatic lesions for patients with papillary and follicular thyroid cancer who have undergone total thyroidectomy. However, false-positive I-131 accumulations are often seen in cases of body secretions, pathologic exudates, inflammation, and nonthyroidal neoplasms. Thymic cyst as well as thymic hyperplasia, 3-6 bronchogenic cyst, 7 and pleuropericardial cyst 8 can cause false-positive imaging of mediastinal I-131 uptake. It is necessary to recognize various types of false-positive I-131 uptake to prevent unnecessary therapy.
